Charles D. Searles, David G. Harrison
Title and authors | Publication | Year |
---|---|---|
LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice
Munkhjargal U, Fukuda D, Maeda J, Hara T, Okamoto S, Bavuu O, Yamamoto T, Sata M |
Journal of Atherosclerosis and Thrombosis | 2024 |
The Link Between Heat Shock Proteins, Renin-Angiotensin System, and the Coagulation Cascade in the Pathogenesis of the Coronavirus-19 Disease.
Saha A, Ahmed S |
Advances in experimental medicine and biology | 2023 |
Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID ‐19?
AS Gouda, B Mégarbane |
Drug Development Research | 2020 |
Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
RK Trivedi, DJ Polhemus, Z Li, D Yoo, H Koiwaya, A Scarborough, TT Goodchild, DJ Lefer |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2018 |
Beneficial effects of rosiglitazone and losartan combination in diabetic rats
H Ateyya, MA Nader, NA El-Sherbeeny |
Canadian Journal of Physiology and Pharmacology | 2017 |
The Angiotensin II Type 2 Receptor in Brain Functions: An Update
MO Guimond, N Gallo-Payet |
International Journal of Hypertension | 2012 |
How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?
MO Guimond, N Gallo-Payet |
Frontiers in Endocrinology | 2012 |
Heart Failure: A Companion to Braunwald's Heart Disease
A Diwan, GW Dorn |
Heart Failure: A Companion to Braunwald's Heart Disease | 2011 |
Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
RS Deeb, BD Lamon, DP Hajjar |
Current hypertension reviews | 2009 |
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study
T Sawada, H Yamada, B Dahlof, H Matsubara |
European Heart Journal | 2009 |
Effects of Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Antagonist Combination on Nitric Oxide Bioavailability and Atherosclerotic Change in Watanabe Heritable Hyperlipidemic Rabbits
T IMANISHI, A KUROI, H IKEJIMA, K KOBAYASHI, Y MURAGAKI, S MOCHIZUKI, M GOTO, K YOSHIDA, T AKASAKA |
Hypertension Research | 2008 |
Effect of chronic inhibition of converting enzyme on proximal tubule acidification
PL Diaz-Sylvester, MC Fiori, SM Dieguez, AC Müller, ML Lopardo, CE Amorena |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2008 |
Cardiovascular Medicine
JT Willerson, HJ Wellens, JN Cohn, DR Holmes |
2007 | |
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism
VD Colonna, S Fioretti, A Rigamonti, S Bonomo, B Manfredi, EE Muller, F Berti, G Rossoni |
Journal of Hypertension | 2006 |
Molecular Mechanisms in Hypertension
T Shimosawa, T Fujita, R Watson, S Supowit, D DiPette |
Molecular Mechanisms in Hypertension: paracrine regulator of salt sensitivity and blood pressure | 2006 |
Effects of Angiotensin II Type 1 Receptor Blockade on the Systemic Blood Nitric Oxide Dynamics in N.OMEGA.-Nitro-L-Arginine Methyl Ester-Treated Rats
Y KANEMATSU, K TSUCHIYA, H OHNISHI, Y MOTOBAYASHI, Y IZAWA, M ISHIHARA, K ISHIZAWA, S ABE, K KAWAZOE, T TAMAKI |
Hypertension Research | 2006 |
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in l-NAME-induced hypertensive rats
VD Colonna, A Rigamonti, S Fioretti, S Bonomo, B Manfredi, P Ferrario, M Bianchi, F Berti, EE Muller, G Rossoni |
European Journal of Pharmacology | 2005 |
Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man
JS Sim, C Farquharson, AD Struthers |
Journal of Renin-Angiotensin-Aldosterone System | 2004 |
Angiotensin Vol. I
T Unger, BA Schölkens |
2004 | |
Inflammation in early atherogenesis: impact of ACE inhibition
RD Caterina, C Manes |
European Heart Journal Supplements | 2003 |
Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria
KC Tan, WS Chow, VH Ai, KS Lam |
Diabetes/Metabolism Research and Reviews | 2002 |
ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors
AJ Turner, SR Tipnis, JL Guy, GI Rice, NM Hooper |
Canadian Journal of Physiology and Pharmacology | 2002 |
Progress in focus: recent advances in Histochemistry and Cell Biology
E Asan |
Histochemistry and Cell Biology | 2002 |
Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase
B Hornig, U Landmesser, C Kohler, D Ahlersmann, S Spiekermann, A Christoph, H Tatge, H Drexler |
Circulation | 2001 |
Mechanisms regulating angiotensin II responsiveness by the uteroplacental circulation
CR Rosenfeld |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2001 |
Update: Role of the angiotensin type-2 (AT2) receptor in blood pressure regulation
RM Carey, ZQ Wang, HM Siragy |
Current Hypertension Reports | 2000 |
Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation
RM Carey, ZQ Wang, HM Siragy |
Current Hypertension Reports | 2000 |
Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides
DJ Campbell |
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas / Sociedade Brasileira de Biofisica ... [et al.] | 2000 |
ACE inhibitors, angiotensin receptor antagonists and bradykinin
M Schachter |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |